Colgate-Palmolive Tops Estimates at $5.37 Billion as Base Business EPS Hits $0.97
The company narrowed its full-year sales growth outlook and raised its gross margin and Base Business EPS guidance.
Colgate Palmolive CL
Colgate Palmolive Co · NYSE · Perfumes, Cosmetics & Other Toilet Preparations
$95.29+2.29%close on Oct. 30, 2026 · volume 8.6M · Yahoo Finance
Price, last 49 sessions
Our coverage
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 24, 2026 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin · indirect | Sold | 10,000 | $92.05 | $920,477 |
| Aug. 6, 2026 | John T. Cahill director | Sold | 4,170 | $93.37 | $389,358 |
| Aug. 5, 2026 | Noel R. Wallace Chairman, President & CEO, director | Sold | 161,021 | $92.52 | $14.90 million |
| Aug. 4, 2026 | Noel R. Wallace Chairman, President & CEO, director | Sold | 161,021 | $91.92 | $14.80 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 26 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedColgate-Palmolive Q3 2026 Base Business EPS of $0.97 beats $0.93 consensus and revenue of $5.37 billion tops $5.33 billion; full-year Base Business EPS growth guidance raised to 5% to 7%